CoChat

Gonadotrophin-Releasing Hormone Analogues for Pain Associated With Endometriosis

· 2011 · Obstetrics & Gynecology
Cited by 36

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Endometriosis is a common gynecological condition, characterized by the presence of endometrial tissue in sites other than the uterine cavity (excluding adenomyosis) that frequently presents with pain. The gonadotrophin-releasing hormone analogues (GnRHas) comprise one intervention that has been offered for pain relief in premenopausal women. GnRHas can be administered intranasally, by subcutaneous injection, or intramuscular injection. They are thought to result in down regulation of the pituitary and induce a hypogonadotrophic hypogonadal state. OBJECTIVE: To determine the effectiveness and safety of GnRHas in the treatment of the painful symptoms associated with endometriosis. SEARCH STRATEGY: Electronic searches of the Cochrane Menstrual Disorders and Subfertility Group specialist register, CENTRAL, MEDLINE, EMBASE, PSYCInfo and CINAHL, were conducted in April 2010 to identify relevant randomized controlled trials. SELECTION CRITERIA: Randomized controlled trials of GnRHas as treatment for pain associated with endometriosis compared with no treatment, placebo, danazol, intra-uterine progestagens, or other GnRHas were included. Trials using add-back therapy, oral contraceptives, surgical intervention, GnRH antagonists, or complementary therapies were excluded. DATA COLLECTION AND ANALYSIS: Quality assessment and data extraction were performed independently by two reviewers. The primary outcome was pain relief. Relative risk (RR) was used as the measure of effect for dichotomous data. For continuous data, mean differences or standardized mean differences were used. MAIN RESULTS: Forty one trials (n=4935 women) were included. The evidence suggested that GnRHas were more effective at symptom relief than placebo or no treatment. There was no statistically significant difference between GnRHas and danazol for dysmenorrhoea RR 0.98 (95% confidence interval [CI], 0.92 to 1.04, P = .53). This equates to 3 fewer women per 1000 (95% CI, 12 to 6) with symptomatic pain relief in the GnRHa group. More adverse events were reported in the GnRHa group. There was a benefit in overall resolution for GnRHas RR1.10 (95% CI, 1.01 to 1.21, P = .03) compared with danazol. There was no statistically significant difference in overall pain between GnRHas and levonorgestrel SMD −0.25 (95% CI, −0.60 to 0.10, P = .46). Evidence was limited on optimal dosage or duration of treatment for GnRHas. No route of administration appeared superior to another. AUTHORS' CONCLUSION: GnRHas appear to be more effective at relieving pain associated with endometriosis than placebo or no treatment. There was no evidence of a difference in pain relief between GnRHas and danazol, although more adverse events were reported in the GnRHa groups. There was no evidence of a difference in pain relief between GnRHas and levonorgestrel, and no studies compared GnRHas with analgesics.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/aog.0b013e31820cb0fd

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 1

  1. 2010, ACOG Practice Bulletin No. 113. American College of Obstetricians and Gynecologists., Obstet Gynecol, 116, 223

Cited by

See all 36

Metadata

Venue
Obstetrics & Gynecology
Published
2011-03
Volume
117
Issue
3
Pages
727-728
ISSN
0029-7844 (ISSN-L)
OpenAlex
W2412424792
Cited by
36
References
2
FWCI
1.61
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gonadotrophin-Releasing Hormone Analogues for Pain Associated With Endometriosis. https://app.cochat.ai/papers/10.1097/aog.0b013e31820cb0fd
The paper
Gonadotrophin-Releasing Hormone Analogues for Pain Associated With Endometriosis. (2011). Obstetrics & Gynecology. https://doi.org/10.1097/aog.0b013e31820cb0fd

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.